Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Roy Frei"'
Autor:
Alain Amstutz, Stefan Schandelmaier, Roy Frei, Jakub Surina, Arnav Agarwal, Reem Alturki, Belinda von Niederhäusern, Erik von Elm, Matthias Briel, on behalf of the MAking Randomized Trials Affordable (MARTA) Group
Publikováno v:
Swiss Medical Weekly, Vol 148, Iss 0304 (2018)
AIMS OF THE STUDY Failure to publish publicly funded research represents a waste of scarce research resources across medical disciplines and countries. In Switzerland, about 40% of randomised clinical trials (RCTs) supported by the Swiss National Sc
Externí odkaz:
https://doaj.org/article/9ef7ac137c8a4ab6a46a38a73d5c72bb
Autor:
Nicolas Fournier, Philipp Schreiner, Roy Frei, Stephan R. Vavricka, Bernhard Morell, Benjamin Misselwitz, Thomas Greuter, Luc Biedermann, Gerhard Rogler, Ekaterina Safroneeva, Jonas Zeitz, Alain M. Schoepfer, Michael Scharl
Publikováno v:
Frei, Roy; Fournier, Nicolas; Zeitz, Jonas; Scharl, Michael; Morell, Bernhard; Greuter, Thomas; Schreiner, Philipp; Misselwitz, Benjamin; Safroneeva, Ekaterina; Schoepfer, Alain M; Vavricka, Stephan R; Rogler, Gerhard; Biedermann, Luc (2019). Early Initiation of Anti-Tnf is Associated with Favourable Long-Term Outcome in Crohn's Disease: 10-Year-Follow-Up Data from the Swiss IBD Cohort Study. Journal of Crohn's & Colitis, 13(10), pp. 1292-1301. Elsevier 10.1093/ecco-jcc/jjz057
Background and Aims The optimal timing of treatment escalation in Crohn’s disease [CD] remains a challenging issue, and very little is known about its long-term development following early versus late administration of anti-TNF antibodies. The long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997d8b07720e35c38fb431a4ff2e99a2
https://doi.org/10.1093/ecco-jcc/jjz057
https://doi.org/10.1093/ecco-jcc/jjz057
Autor:
Erik von Elm, Roy Frei, Arnav Agarwal, Reem Alturki, Stefan Schandelmaier, Lotty Hooft, Belinda von Niederhäusern, Matthias Briel, Neera Bhatnagar, Kelechi K Olu
Publikováno v:
Journal of Clinical Epidemiology
Europe PubMed Central
Journal of Clinical Epidemiology, 81, 56. Elsevier USA
Europe PubMed Central
Journal of Clinical Epidemiology, 81, 56. Elsevier USA
Background One quarter of randomized clinical trials (RCTs) are prematurely discontinued and frequently remain unpublished. Trial registries can document whether a trial is ongoing, suspended, discontinued, or completed and therefore represent an imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::023c37ae3c7fd0c382f14bd328ecd3fc
http://www.sciencedirect.com/science/article/pii/S0895435616304036
http://www.sciencedirect.com/science/article/pii/S0895435616304036
Autor:
Reem Alturki, Belinda von Niederhäusern, Matthias Briel, Stefan Schandelmaier, Kelechi K Olu, Arnav Agarwal, Jakub Surina, Alain Amstutz, Roy Frei, Erik von Elm
Publikováno v:
BMJ Open
BMJ open, vol. 7, no. 7, pp. e016216
BMJ open, vol. 7, no. 7, pp. e016216
Objective The Swiss National Science Foundation (SNSF) promotes academic excellence through competitive selection of study proposals and rigorous evaluation of feasibility, but completion status and publication history of SNSF-supported randomised cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c362a013646106940adaaa4bc2f9e6f8
http://europepmc.org/articles/PMC5642669
http://europepmc.org/articles/PMC5642669
Autor:
Benjamin Misselwitz, Bernhard Morell, Luc Biedermann, Michael Scharl, Ekaterina Safroneeva, Gerhard Rogler, Jonas Zeitz, Philipp Schreiner, Nicolas Fournier, Stephan R. Vavricka, Thomas Greuter, Alain M. Schoepfer, Roy Frei
Publikováno v:
Gastroenterology. 154:S-828
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a563aa8cbc622923999da333e12e342b
https://doi.org/10.1016/s0016-5085(18)32823-3
https://doi.org/10.1016/s0016-5085(18)32823-3